Alpha-Lipoic Acid for Weight Loss

Verdict: A real but clinically trivial effect

Alpha-lipoic acid produces a small, statistically real reduction in body weight versus placebo, but the effect is too modest to be clinically meaningful and no medical guideline endorses it for weight loss. It is not a substitute for diet, exercise, or proven anti-obesity treatment.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

Three independent meta-analyses agree that alpha-lipoic acid beats placebo on the scale, but only slightly: body weight fell by about 1.27 kg (PMID 28295905), 0.69 kg (PMID 28629898), and 2.29 kg (PMID 32091656), with BMI down roughly 0.4-0.5 kg/m2. Waist circumference did not change significantly in the two analyses that measured it, and the largest trial (PMID 21187189, 360 obese adults, 20 weeks) found a clear effect only at a high 1800 mg/day dose, near the upper safety bound.

The signal is consistent but commercially overstated. The 2018 meta-analysis authors concluded ALA cannot be cost-effective for obesity treatment (PMID 28629898), and a 2025 meta-analysis of 704 adults found no effect on intermediate metabolic markers such as cholesterol, glucose, or insulin resistance (PMID 40180416). Point estimates vary widely between analyses and trial funding is largely undisclosed, so industry conflict of interest cannot be ruled out.

No regulator or clinic endorses ALA for weight loss. The US FDA treats it as a supplement never approved to treat disease, the EU's EFSA rejected its health claims, and the UK NHS says the evidence is not always clear. Mayo Clinic mentions it only in passing as possibly effective, while a relevant specialty society advises against supplement-based weight loss. A real but minor, replicated effect with no guideline backing is why this earns a Preliminary (B) grade, published with a warning.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.56
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
77%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.31
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L3 MechanismPlausibility
0.65
L2 PubMedPrimary literature
0.75
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.565
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 1 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials
PMID: 28295905 2017 統合分析
Finding: Across 10 randomized double-blind placebo-controlled trials, ALA produced a small but statistically significant weight loss of 1.27 kg versus placebo (95% CI 0.25 to 2.29, p=0.015) and a BMI reduction of -0.43 kg/m2 (95% CI -0.82 to -0.03, p=0.033); authors characterize the effect as 「small, yet significant short-term weight loss」.
Government Effect size: WMD weight -1.27 kg; BMI -0.43 kg/m2
View on PubMed
Alpha-lipoic acid supplement in obesity treatment: A systematic review and meta-analysis of clinical trials
PMID: 28629898 2018 統合分析
Finding: Across 12 clinical trials ALA slightly but significantly reduced body weight by -0.69 kg (95% CI -1.27 to -0.10, I2=0%) and BMI by -0.38 kg/m2 (95% CI -0.53 to -0.24, I2=0%); waist circumference change was not significant (-0.30 cm, 95% CI -1.18 to 0.58). Authors explicitly conclude ALA 「cannot be cost-effective」 for obesity treatment.
Effect size: WMD weight -0.69 kg; BMI -0.38 kg/m2; waist NS
View on PubMed
Alpha-lipoic acid supplementation significantly reduces the risk of obesity in an updated systematic review and dose response meta-analysis of randomised placebo-controlled clinical trials
PMID: 32091656 2020 統合分析
Finding: Across 18 trials (weight) and 21 trials (BMI) ALA reduced weight by -2.29 kg (95% CI -2.98 to -1.60, p<0.01) and BMI by -0.49 kg/m2 (95% CI -0.83 to -0.15, p=0.005); waist circumference was not significantly reduced (-2.57 cm, 95% CI -8.91 to 3.76, p=0.426). This MA reports the largest weight effect of the three but with wider scope.
Effect size: WMD weight -2.29 kg; BMI -0.49 kg/m2; waist NS
View on PubMed
Effects of alpha-lipoic acid on body weight in obese subjects
PMID: 21187189 2011 隨機對照試驗 n = 360
Finding: In 360 obese adults over 20 weeks, the 1800 mg/day group lost 2.1% of body weight versus placebo (95% CI 1.4 to 2.8%, p<0.05); the 1200 mg/day group did not reach a clearly significant difference, indicating a modest, dose-dependent effect at high (>=1800 mg) doses.
Effect size: 1800 mg arm: -2.1% body weight vs placebo
View on PubMed
Alpha-lipoic acid on intermediate disease markers in overweight or obese adults: a systematic review and meta-analysis
PMID: 40180416 2025 統合分析 n = 704
Finding: Across 11 RCTs (704 overweight/obese adults) ALA showed no significant effect on any intermediate metabolic marker (all p>0.05, CIs crossing zero); body weight and BMI were not the primary endpoints, so this study limits but does not directly quantify the weight effect.
Government Effect size: Metabolic markers all NS; weight not a primary endpoint
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
The Only Natural Alpha Lipoic Acid Plus product is a drug under section 201(g)(1) of the Act ... because it is intended for use in the cure, mitigation, treatment, or prevention of disease. source↗
L4b EU EFSA
Against
L4c UK NHS
Cautious
alpha-lipoic acid (an antioxidant) supplements ... while some people may find these helpful, the evidence for them is not always clear. source↗
L4d TW TFDA / 衛福部
Neutral
「台裕」久克坦注射液(硫辛酸)THIOCTAN INJECTION (THIOCTIC ACID) 「TAI YU」,許可證字號 衛署藥製字第019276號。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Neutral
alpha-lipoic acid has been used in alternative medicine as a possibly effective aid in weight loss, treating diabetic nerve pain, healing wounds, lowering blood sugar source↗
L5e Specialty Society (condition-mapped)
Against
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-weight-loss-INT-alpha-lipoic-acid-001 繁體中文版 →